搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
ENDPOINTS NEWS
13 小时
A Q&A with a Nobel Prize winner; Pfizer meets with Starboard; J&J reports Q3 earn ...
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday ...
ENDPOINTS NEWS
1 天
Apertura and Atalanta reduce headcount en route toward the clinic
Two central nervous system disorder biotechs laid off employees recently. New York gene therapy startup Apertura and Boston ...
ENDPOINTS NEWS
1 天
FDA won't take action against GLP-1 compounders as it rethinks tirzepatide shortage
The FDA clarified Thursday that it won't take action against GLP-1 compounders for certain violations while it reevaluates ...
ENDPOINTS NEWS
1 天
FDA approves Astellas' gastric cancer drug Vyloy ahead of schedule
The FDA on Friday approved Astellas’ treatment for a type of gastric cancer, marketed as Vyloy (zolbetuximab). The approval ...
ENDPOINTS NEWS
1 天
Exclusive: Ex-Affimed CEO heads to UK nanomedicine biotech; Jami Rubin leaves ...
Adi Hoess describes himself as someone who “likes to build” companies focused on “challenging technologies.” It’s fitting, ...
ENDPOINTS NEWS
1 天
NJ judge tosses Novartis' IRA lawsuit another win for government
Novartis has lost its legal challenge against the Inflation Reduction Act on Friday, making it the sixth drugmaker rejected ...
ENDPOINTS NEWS
1 天
Lykos is optimistic about MDMA treatment after meeting with FDA
Lykos Therapeutics said it had a “productive” meeting with the FDA to discuss a path forward for its recently rejected PTSD ...
ENDPOINTS NEWS
1 天
Pfizer ends trial of Array-acquired SHP2 inhibitor after similar cuts from ...
Pfizer has ended its trial of an SHP2 inhibitor that was being developed in cancer, the latest blow to the target after ...
ENDPOINTS NEWS
1 天
Merck unveils RSV antibody data, in bid to compete with AstraZeneca and Sanofi
Merck’s experimental antibody for RSV reduced infants’ risk of certain lower respiratory infections by 60.4% compared to ...
ENDPOINTS NEWS
2 天
Pfizer’s RSV vaccine has 90% efficacy against severe respiratory dis ...
Pfizer's RSV vaccine was 90% effective at preventing the most severe outcomes in the first-ever vaccination season, the ...
ENDPOINTS NEWS
2 天
Secretive Treeline Biosciences discloses $421M financing in filing
Josh Bilenker and Jeff Engelman's secretive startup Treeline Biosciences has another $421 million, according to a new SEC ...
ENDPOINTS NEWS
1 天
Gilead pulls Trodelvy's accelerated label in bladder cancer after drug ...
Gilead is withdrawing the accelerated approval for its blockbuster antibody-drug conjugate Trodelvy for bladder cancer after ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈